Sexual Health & Hormonal Stacks

PT-141 (Bremelanotide) + Oxytocin + Tadalafil

PT-141 + Oxytocin + Tadalafil ("Olympus")

T3 · EmergingScore 42 · D

PT-141 (Bremelanotide) — cyclic heptapeptide, MC3R/MC4R melanocortin receptor agonist, FDA-approved as Vyleesi (SC injection only) for HSDD in premenopausal womenOxytocin — synthetic nonapeptide, oxytocin receptor agonist ('bonding hormone'), off-label/compounded, not FDA-approved for this indication via any routeTadalafil — PDE5 inhibitor, FDA-approved generic (Cialis) for ED/BPH/PAH — the only component with genuinely robust independent RCT backing for a sexual-health indication

Compounds

Format

Blend

What this stack is for

A three-lever "complete" sexual-wellness troche marketed to hit central desire (PT-141), emotional bonding/connection (oxytocin), and peripheral erectile blood flow (tadalafil) in a single as-needed dose — but forum reports on the actual compounded troche are notably more mixed than the vendor copy selling it.

Why it matters

A single on-demand troche stacks three separate levers: PT-141 to trigger desire in the brain, oxytocin for bonding and orgasm feeling, and tadalafil (the Cialis drug) to boost blood flow for an erection.

The full protocol

Compounds in this stack

PT-141 (Bremelanotide) — cyclic heptapeptide, MC3R/MC4R melanocortin receptor agonist, FDA-approved as Vyleesi (SC injection only) for HSDD in premenopausal womenIn this stack

Oxytocin — synthetic nonapeptide, oxytocin receptor agonist ('bonding hormone'), off-label/compounded, not FDA-approved for this indication via any routeIn this stack

Tadalafil — PDE5 inhibitor, FDA-approved generic (Cialis) for ED/BPH/PAH — the only component with genuinely robust independent RCT backing for a sexual-health indicationIn this stack

PT-141 (Bremelanotide) + Oxytocin + Tadalafil

Unlock the full protocol